Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Parkinson Disease 4, Autosomal Dominant Lewy Body × spartalizumab × Clear all

Sponsor

Conditions

Melanoma 7 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 3 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1

Interventions

pembrolizumab 103 Cisplatin 23 Carboplatin 22 Paclitaxel 20 Docetaxel 14 lenvatinib 13 Saline Solution 10 Pemetrexed 10 epacadostat 8 Fluorouracil 8 Gemcitabine 7 Capecitabine 7 Cetuximab 5 olaparib 4 Bevacizumab 4 130-nm albumin-bound paclitaxel 4 enzalutamide 3 Prednisone 3 Oxaliplatin 3 Leucovorin 3 Irinotecan 3 Dexamethasone 3 Albumin-Bound Paclitaxel 3 trifluridine tipiracil drug combination 2 regorafenib 2 Radiotherapy 2 Ipilimumab 2 Glucose 2 Etoposide 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡